HBW Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CHATTEM SALES DECLINE 1.7% TO $20.8 MIL. IN FIRST QUARTER

This article was originally published in The Rose Sheet

Executive Summary

CHATTEM SALES DECLINE 1.7% TO $20.8 MIL. IN FIRST QUARTER (ended Feb. 28) due to the loss of Warner-Lambert as a major customer of its chemical division, Chattem said in a recent sales and earnings statement. Warner-Lambert terminated its arrangement with Chattem Chemicals when it reformulated Rolaids antacid in the middle of last year.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

RS000300

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel